EP1651760A4 - Proteines sanguines humaines exprimees dans des graines de monocotyledone - Google Patents

Proteines sanguines humaines exprimees dans des graines de monocotyledone

Info

Publication number
EP1651760A4
EP1651760A4 EP03714394A EP03714394A EP1651760A4 EP 1651760 A4 EP1651760 A4 EP 1651760A4 EP 03714394 A EP03714394 A EP 03714394A EP 03714394 A EP03714394 A EP 03714394A EP 1651760 A4 EP1651760 A4 EP 1651760A4
Authority
EP
European Patent Office
Prior art keywords
human blood
proteins expressed
blood proteins
monocot seeds
monocot
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03714394A
Other languages
German (de)
English (en)
Other versions
EP1651760A1 (fr
Inventor
Ning Huang
Raymond L Rodriquez
Frank E Hagie
David M Stalker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Invitria Inc
Original Assignee
Ventria Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ventria Bioscience Inc filed Critical Ventria Bioscience Inc
Publication of EP1651760A1 publication Critical patent/EP1651760A1/fr
Publication of EP1651760A4 publication Critical patent/EP1651760A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
EP03714394A 2003-04-11 2003-04-11 Proteines sanguines humaines exprimees dans des graines de monocotyledone Withdrawn EP1651760A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2003/009209 WO2004099405A1 (fr) 2003-04-11 2003-04-11 Proteines sanguines humaines exprimees dans des graines de monocotyledone

Publications (2)

Publication Number Publication Date
EP1651760A1 EP1651760A1 (fr) 2006-05-03
EP1651760A4 true EP1651760A4 (fr) 2006-10-18

Family

ID=33434296

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03714394A Withdrawn EP1651760A4 (fr) 2003-04-11 2003-04-11 Proteines sanguines humaines exprimees dans des graines de monocotyledone

Country Status (5)

Country Link
EP (1) EP1651760A4 (fr)
JP (1) JP2006522585A (fr)
AU (1) AU2003218396B2 (fr)
CA (1) CA2525493C (fr)
WO (1) WO2004099405A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005067699A1 (fr) * 2003-12-23 2005-07-28 Ventria Bioscience Procedes permettant d'exprimer une proteine heterologue dans des graines vegetales a l'aide de promoteurs de proteines de graines de monocotyledone autres que des proteines de reserve
WO2006108830A2 (fr) * 2005-04-13 2006-10-19 Bayer Cropscience Sa Vegetaux transplastomiques exprimant l'$g(a)1-antitrypsine
EP2016181B1 (fr) 2006-05-12 2013-04-17 Monsanto Technology, LLC Procédés et compositions pour l'élaboration de plantes transgéniques sans marqueur
WO2010004004A1 (fr) * 2008-07-09 2010-01-14 Profibrix Bv Fibrinogène recombiné
CN102127164B (zh) 2010-12-20 2013-01-30 武汉禾元生物科技有限公司 一种从水稻种子中提取重组人血清白蛋白的方法
CN102532254B (zh) 2010-12-24 2015-06-24 武汉禾元生物科技股份有限公司 一种从水稻种子中分离纯化重组人血清白蛋白的方法
CN102994514B (zh) * 2012-11-07 2015-06-10 武汉禾元生物科技股份有限公司 一种从水稻种子生产和分离纯化重组人抗胰蛋白酶(OsrAAT)的方法
CN103880947B (zh) 2012-12-21 2016-01-13 武汉禾元生物科技股份有限公司 一种分离纯化高纯度重组人血清白蛋白的层析方法
LT3044320T (lt) * 2013-09-11 2020-06-10 Impossible Foods Inc. Hemo turinčių polipeptidų sekrecija
KR102229968B1 (ko) 2015-05-11 2021-03-22 임파서블 푸즈 인크. 메틸영양성 효모를 유전적으로 조작하는 발현 구축물 및 방법
CN109355291B (zh) * 2018-11-22 2022-01-18 深圳市作物分子设计育种研究院 一种植物胚乳特异性表达启动子pOsEnS93的鉴定和应用
JP2022531140A (ja) 2019-04-25 2022-07-06 インポッシブル フーズ インコーポレイテッド ヘム含有タンパク質の作製のための株および方法
WO2024003668A1 (fr) * 2022-06-29 2024-01-04 Moolec Science Limited Expression élevée de protéine héminique animale dans des plantes

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6344600B1 (en) * 1995-07-17 2002-02-05 Meristem Therapeutics Method for producing human hemoglobin proteins using plant cells
WO2002064750A2 (fr) * 2001-02-14 2002-08-22 Ventria Bioscience Systeme d'expression de proteines de graines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693506A (en) * 1993-11-16 1997-12-02 The Regents Of The University Of California Process for protein production in plants

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6344600B1 (en) * 1995-07-17 2002-02-05 Meristem Therapeutics Method for producing human hemoglobin proteins using plant cells
WO2002064750A2 (fr) * 2001-02-14 2002-08-22 Ventria Bioscience Systeme d'expression de proteines de graines

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HUANG J ET AL: "Expression and purification of functional human alpha-1-antitrypsin from cultured plant cells", BIOTECHNOLOGY PROGRESS, XX, XX, vol. 17, no. 1, 30 December 2000 (2000-12-30), pages 126 - 133, XP002367520, ISSN: 8756-7938 *
See also references of WO2004099405A1 *

Also Published As

Publication number Publication date
EP1651760A1 (fr) 2006-05-03
CA2525493C (fr) 2018-10-30
JP2006522585A (ja) 2006-10-05
AU2003218396B2 (en) 2008-09-04
WO2004099405A1 (fr) 2004-11-18
AU2003218396A1 (en) 2004-11-26
CA2525493A1 (fr) 2004-11-18

Similar Documents

Publication Publication Date Title
EP1594569A4 (fr) Dispositif in vivo destine a ameliorer la fonction ventriculaire diastolique
IL166809A (en) Aqueous liquid compositions contain human antibodies against a tnf
GB0321911D0 (en) Improvements in or relating to medical devices
EP1651760A4 (fr) Proteines sanguines humaines exprimees dans des graines de monocotyledone
GB0410012D0 (en) Open patient care unit
IL172511A0 (en) Specific human antibodies
GB0306604D0 (en) Second medical use
EP1603467A4 (fr) Dispositif de prelevement de vaisseaux sanguins
AU2003226899A8 (en) Human diabetes-mediating proteins
EP1682572A4 (fr) Expression de proteines
EP1838728A4 (fr) Protooncogene humain et proteine codee dans ce dernier
EP1602666A4 (fr) Nouvelle proteine et son adn
AU2003229752A1 (en) Human rhomboid-related protein
GB0321018D0 (en) Saline preparations for clinical use
IL154141A (en) In vivo device for improving diastolic ventricular function
IL175263A0 (en) In vivo device for improving diastolic ventricular function
GB0321300D0 (en) Protein structure and uses thereof
GB0417544D0 (en) Saline preparations for clinical use
GB0300547D0 (en) Medical poultices
PL1693378T3 (pl) Białko NMB1125 i jego zastosowanie w kompozycjach farmaceutycznych
GB0314065D0 (en) Protein
GB0308979D0 (en) Protein
GB0300719D0 (en) Protein
GB0301253D0 (en) Protein
GB0302112D0 (en) Protein

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20051110

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20060919

17Q First examination report despatched

Effective date: 20070319

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070731